I think everybody is on the same page. The question really is, ‘Will the new environment in my lungs and body, due to Kalydeco, allow the body/antibiotics to eradicate resistant microbial colonies?” It is a great question, in fact a fantastic question for the future of all CFers.
The answer in part has to do with the types of microbes, bacterial, fungal and viral. Multiple Drug Resistant or MDR bacteria are mostly what the original question was asking about like p.A., MAC and MRSA. Ideally, once the environment in the body becomes undesirable for infection, those that can be eradicated, either by the body’s own defenses or antibiotics should be cleaned out. It looks like it will take a long time for the body to recover. This isn’t a big surprise, I would expect minimum of a year on Kalydeco to see any improvement beyond, not just being so sick. Being on Kalydeco definitely gives an advantage for resisting all future infections because the body can now move mucus and its quarry of pollen and pathogens up and out.
Those that have colonies in the lungs may be in for the long haul. When a colony of bacteria takes hold in the lungs and they can’t get rid of that colony, the lungs wall the infection in. This keeps the infection away from the lungs, but many colonies thrive in their new protective homes away from our blood supply. At some time, the chrysalise may be treated or otherwise removed. TB was famous for being bound up in chrysalise throughout the body, in fact they were said to be consumed by them, hence the other name for TB, consumption. MAC’s and MRSA’s are tubercular pathogens and my guess is they will be fully sealed in as general health improves. In a few years, the antigen levels for MRSA and such will begin to drop but never go away.
MDR bugs are near to impossible to treat by definition and it just makes matters worse when the body’s natural defenses are mechanically compromised. As lungs become moist and the cilia regenerate, assuming they can, and the mucus thins, our lungs begin to function like the filter queens they were meant to be.
The mechanical blocks, keeping our immune system at bay like thick, desiccated mucus lining everything is eventually cleansed after a time on Kalydeco. At least that’s the logic. Although the mucus is now thin and does its job properly, CF seems to have some other issues that I don’t know if Kalydeco can correct.
Most CFers have smaller than usual plumbing or duct work. My Eustachian tubes, pancreatic and bile ducts, sinus openings and every gland from the salivary to the urogenital system are replete with thin sticky tubing. From my understanding, this is all typical in CF. The potential for blockage in the lungs, is unlimited, it is the ideal target. Kalydeco shows it corrects the genetics in G551D and thins mucus throughout the body. This relieves about half of the stress on the body just by normalizing mucus.
I don’t know that the narrower than normal tubing and openings in our bodies will improve. I expect they will stop being physically adhesive or sticky and certainly the mucus will be less inclined to adhere to the walls of our plumbing systems. This common problem with CF may be the result of the CFTR gene error, if so it may reverse itself here after some time. I assume this would be something that affects the growth and structure of our sticky ducting from birth, maybe in the womb.
My question is in part why do CFers have narrow sticky ducting? If poor functioning mucus cells are engorging the walls of the fallopian tubes or common bile duct, maybe the duct works in our bodies will shrink at the walls, leaving closer to normal sized ducts and ports. This is not something I am reading anything about, has anybody leaned what effect Kalydeco might have on the structure of the ducting? This would be a thinning of the duct walls and potentially an opening or widening of all swollen tissue, aggravated by CF. At a larger scale scarring from repeated infections have deformed and distorted our lungs and such and that won't revert.
Anybody have any thoughts?
LL
This question and others remain to be answered and they may be part of our new leases on life.
LL